Citigroup Equity Method Investments increased by 10.5% to $1.71B in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 8.4%, from $1.57B to $1.71B.
An increase indicates strategic expansion through partnerships or joint ventures, while a decrease may signal divestments or impairment.
These are investments in entities where the company exercises significant influence but does not have full control. The...
Varies significantly based on corporate strategy; common in healthcare companies that partner with biotech startups or specialized diagnostic firms.
equity_method_investments| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.68B | $1.62B | $1.62B | $1.62B | $1.64B | $1.71B | $1.72B | $1.76B | $1.57B | $1.54B | $1.58B | $1.55B | $1.71B |
| QoQ Change | — | — | — | — | — | — | — | -3.4% | -0.1% | +0.2% | +1.1% | +4.1% | +0.6% | +2.6% | -10.7% | -2.1% | +2.6% | -2.3% | +10.5% |
| YoY Change | — | — | — | — | — | — | — | — | — | — | -2.2% | +5.4% | +6.1% | +8.7% | -4.0% | -9.7% | -7.9% | -12.3% | +8.4% |
We use cookies for analytics. See our Privacy and Cookie Policy.